These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2614272)

  • 1. Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation.
    Barnhart RL; Busch SJ; Jackson RL
    J Lipid Res; 1989 Nov; 30(11):1703-10. PubMed ID: 2614272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural changes in oxidised low-density lipoproteins and of the effect of the anti-atherosclerotic drug probucol observed by synchrotron X-ray and neutron solution scattering.
    Bellamy MF; Nealis AS; Aitken JW; Bruckdorfer KR; Perkins SJ
    Eur J Biochem; 1989 Aug; 183(2):321-9. PubMed ID: 2759086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
    Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
    Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B carbonyl formation is enhanced by lipid peroxidation during copper-mediated oxidation of human low-density lipoproteins.
    Yan LJ; Lodge JK; Traber MG; Packer L
    Arch Biochem Biophys; 1997 Mar; 339(1):165-71. PubMed ID: 9056246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.
    Walters-Laporte E; Furman C; Fouquet S; Martin-Nizard F; Lestavel S; Gozzo A; Lesieur D; Fruchart JC; Duriez P; Teissier E
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein oxidation in the absence of lipid peroxidation enhances LDL uptake by macrophages.
    Hunt JV; Bailey JR; Schultz DL; McKay AG; Mitchinson MJ
    FEBS Lett; 1994 Aug; 349(3):375-9. PubMed ID: 8050600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for the presence of circulating peroxidized low density lipoproteins in WHHL rabbits treated with antioxidants.
    Demacker PN; Hijmans AG; Kleinveld HA; Stalenhoef AF
    Atherosclerosis; 1993 Aug; 102(1):69-77. PubMed ID: 8257454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant effect of probucol on RO2*/O2(*-)-induced peroxidation of human low-density lipoproteins.
    Bonnefont-Rousselot D; Segaud C; Jore D; Delattre J; Gardès-Albert M
    Radiat Res; 1999 Mar; 151(3):343-53. PubMed ID: 10073673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing effects of probucol and vitamin E on the oxidation of lipoproteins, ceroid accumulation and protein uptake by macrophages.
    Hunt JV; Bottoms MA; Taylor SE; Lyell V; Mitchinson MJ
    Free Radic Res; 1994 Mar; 20(3):189-201. PubMed ID: 8019642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of low density lipoprotein oxidation by thyronines and probucol.
    Hanna AN; Feller DR; Witiak DT; Newman HA
    Biochem Pharmacol; 1993 Feb; 45(3):753-62. PubMed ID: 8442772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro.
    Regnström J; Walldius G; Carlson LA; Nilsson J
    Atherosclerosis; 1990 May; 82(1-2):43-51. PubMed ID: 2360919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic interaction between the probucol phenoxyl radical and ascorbic acid in inhibiting the oxidation of low density lipoprotein.
    Kalyanaraman B; Darley-Usmar VM; Wood J; Joseph J; Parthasarathy S
    J Biol Chem; 1992 Apr; 267(10):6789-95. PubMed ID: 1313022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper ions promote peroxidation of low density lipoprotein lipid by binding to histidine residues of apolipoprotein B100, but they are reduced at other sites on LDL.
    Wagner P; Heinecke JW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3338-46. PubMed ID: 9409331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans.
    Reaven PD; Parthasarathy S; Beltz WF; Witztum JL
    Arterioscler Thromb; 1992 Mar; 12(3):318-24. PubMed ID: 1547191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant activity of ubiquinone-3 in human low density lipoprotein.
    Merati G; Pasquali P; Vergani C; Landi L
    Free Radic Res Commun; 1992; 16(1):11-7. PubMed ID: 1516845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals.
    Noguchi N; Gotoh N; Niki E
    Biochim Biophys Acta; 1994 Jul; 1213(2):176-82. PubMed ID: 8025128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients.
    Lussier-Cacan S; Dubreuil-Quidoz S; Roederer G; Leboeuf N; Boulet L; de Langavant GC; Davignon J; Naruszewicz M
    Arterioscler Thromb; 1993 Dec; 13(12):1790-7. PubMed ID: 8241099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of probucol on the physical properties of low-density lipoproteins oxidized by copper.
    McLean LR; Hagaman KA
    Biochemistry; 1989 Jan; 28(1):321-7. PubMed ID: 2706256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of probucol in reducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemia.
    Masana L; Bargalló MT; Plana N; LaVille A; Casals I; Solà R
    Am J Cardiol; 1991 Oct; 68(9):863-7. PubMed ID: 1927944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.